← All organizations
Sunshine Lake Pharma Co., Ltd.
For profit
Also known as: Hec Pharm | HEC PHARM | HEC PHARM CO LTD | Shenyang Sunshine Pharmaceutical Co., LTD. | SUNSHINE | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | SUNSHINE LAKE | Sunshine Lake Pharma Co., Ltd. | SUNSHINE LAKE PHARMA CO LTD | Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Highest phase reached
Phase 4
Timeline
1990s
- Jun 1, 1992
Sunshine Lake Pharma Co., Ltd.— Founded
2010s
- Feb 8, 2019
apixaban— Marketing Organization
Drugs by trial phase (104 distinct, 160 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (30 own, 0 via acquisition)
Phase 2 (31 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Arthritis
- Arthritis, Rheumatoid
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Communicable Diseases
- Depressive Disorder
- Edema
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Fatty Liver
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Idiopathic Pulmonary Fibrosis
- Infections
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Liver Diseases
- Macular Degeneration
- Macular Edema
- Major Depressive Disorder
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Pancreatic Neoplasms
- Pruritus
- Psoriasis
- Pulmonary Eosinophilia
- Pulmonary Fibrosis
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Retinal Vein Occlusion
- Sleep Initiation and Maintenance Disorders
- Spondylitis
- Spondylitis, Ankylosing
- Thrombocytopenia
Marketed drugs (33)
Recent trials (50)
- NCT07233850Lead sponsorPhase 2Nov 30, 2025
- NCT07261644Lead sponsorPhase 3Nov 7, 2025
- NCT07082842Lead sponsorPhase 3Oct 9, 2025
- NCT07171606Lead sponsorPhase 2Sep 30, 2025
- NCT07211165Lead sponsorPhase 1Sep 29, 2025
- NCT07102251Lead sponsorPhase 1Aug 31, 2025
- NCT07099118Lead sponsorPhase 1Aug 14, 2025
- NCT07058779Lead sponsorPhase 1Jul 31, 2025
- NCT07007936Lead sponsorPhase 2Jul 31, 2025
- NCT07042113Lead sponsorPhase 1Jul 31, 2025
- NCT07022002Lead sponsorPhase 2Jul 30, 2025
- NCT07032298Lead sponsorPhase 1Jul 18, 2025
- NCT07038005Lead sponsorPhase 1Jul 13, 2025
- NCT07025915Lead sponsorPhase 1Jun 30, 2025
- NCT06980272Lead sponsorPhase 3Jun 20, 2025
Details
- Founded
- Donguang, CN Jun 1, 1992
- Last known activity
- Apr 29, 2026
Notes
--- Pre-folding founded info: 2003-06-01 Dongguan None China https://www.bloomberg.com/profile/company/0364576D:CH ---